Form 4: Director Gladden Boosts DENTSPLY SIRONA Stake

DENTSPLY SIRONA Director Brian T. Gladden acquired additional common stock through RSU dividends.

Summary

• Brian T. Gladden, a Director of DENTSPLY SIRONA Inc. (XRAY), acquired 314.959 shares of common stock.
• This acquisition occurred on January 9, 2026.
• The shares represent dividends on previously awarded Restricted Stock Units (RSUs).
• These additional RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously.
• Each RSU converts to common stock on a 1:1 basis.
• Following this transaction, Gladden beneficially owns 29,041.522 shares of DENTSPLY SIRONA common stock.

Sentiment

Score: 7

Explanation: The acquisition of additional shares by a director, even if through RSU dividends, generally indicates continued confidence in the company's long-term prospects and aligns insider interests with shareholders.

Positives

• An insider, Director Brian T. Gladden, increased his beneficial ownership in the company by acquiring 314.959 shares.
• The acquisition is a result of dividends on Restricted Stock Units (RSUs), indicating ongoing equity participation and alignment of interests with shareholders.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased alignment of interests between a director and shareholders due to increased equity ownership.

Key Dates

Recommendation

The filing reports a routine acquisition of shares by a director through RSU dividends, which is a minor positive signal of continued insider alignment. However, it does not present new fundamental information significant enough to alter a broader investment thesis or recommendation for DENTSPLY SIRONA Inc. A 'hold' recommendation is appropriate as this transaction alone does not provide a strong catalyst for 'buy' or 'sell'.

Keywords

DENTSPLY SIRONA, XRAY, Insider Trading, Form 4, Brian T Gladden, Director, Common Stock, RSU, Restricted Stock Units, Equity Compensation